2001
DOI: 10.1046/j.1528-1157.2001.08801.x
|View full text |Cite
|
Sign up to set email alerts
|

Loss of the Potassium Channel β‐Subunit Gene, KCNAB2, Is Associated with Epilepsy in Patients with 1p36 Deletion Syndrome

Abstract: Summary:Purpose: Clinical features associated with chromosome 1p36 deletion include characteristic craniofacial abnormalities, mental retardation, and epilepsy. The presence and severity of specific phenotypic features are likely to be correlated with loss of a distinct complement of genes in each patient. We hypothesize that hemizygous deletion of one, or a few, critical gene(s) controlling neuronal excitability is associated with the epilepsy phenotype. Because ion channels are important determinants of seiz… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
91
0
3

Year Published

2002
2002
2020
2020

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 86 publications
(98 citation statements)
references
References 50 publications
4
91
0
3
Order By: Relevance
“…KCNAB2 is a member of the shaker subfamily of voltage-gated potassium channels and serves an auxiliary role to the functional a subunit of the channel (McCormack et al, 2002). Our analysis found this gene to be preferentially expressed in brain, which is consistent with previous findings indicating an association between deletion of KCNAB2 and an epileptic phenotype in patients with monosomy 1p36.3 (Heilstedt et al, 2001). Finally, the transcription factor HKR3 and the death domain receptor TNFRSF25 have previously been identified and extensively evaluated as candidate neuroblastoma tumor suppressor genes Grenet et al, 1998), but no evidence to date implicates either in tumorigenesis.…”
Section: Discussionsupporting
confidence: 91%
“…KCNAB2 is a member of the shaker subfamily of voltage-gated potassium channels and serves an auxiliary role to the functional a subunit of the channel (McCormack et al, 2002). Our analysis found this gene to be preferentially expressed in brain, which is consistent with previous findings indicating an association between deletion of KCNAB2 and an epileptic phenotype in patients with monosomy 1p36.3 (Heilstedt et al, 2001). Finally, the transcription factor HKR3 and the death domain receptor TNFRSF25 have previously been identified and extensively evaluated as candidate neuroblastoma tumor suppressor genes Grenet et al, 1998), but no evidence to date implicates either in tumorigenesis.…”
Section: Discussionsupporting
confidence: 91%
“…Phenotype/ genotype correlation and refinements of critical regions delineated specific areas for the causative genes (Wu et al 1999). For example, hemizygosity of KCNAB2 is a significant risk factor for severe epilepsy (Heilstedt et al 2001). Myopathy in our patient may be explained by haploinsufficiency of the putative causative genes or unmasking of certain recessive alleles.…”
Section: Discussionmentioning
confidence: 77%
“…In the central nervous system, Kv1 family channels are preferentially targeted to axons (31) and likely play an important role in controlling the invasion and propagation of an action potential. In humans, mutations of the Kv1 channel have been linked to episodic ataxia (32), and loss of the Kv␤ gene has been associated with seizures (33). In non-excitable T-lymphocytes, the activity of Kv1 channels changes significantly during the T-cell maturation process (34).…”
Section: Discussionmentioning
confidence: 99%